Value of MRI in medicine: More than just another test?

Edwin J.R. van Beek; Christiane Kuhl; Yoshimi Anzai; Patricia Desmond; Richard L. Ehman; Qiyong Gong; Garry Gold; Vikas Gulani; Margaret Hall-Craggs; Tim Leiner; C. C.Tschoyoson Lim; James G. Pipe; Scott Reeder; Caroline Reinhold; Marion Smits; Daniel K. Sodickson; Clare Tempany; H. Alberto Vargas; Meiyun Wang

doi:10.1002/jmri.26211

Value of MRI in medicine: More than just another test?

Edwin J.R. van Beek, Christiane Kuhl, Yoshimi Anzai, Patricia Desmond, Richard L. Ehman, Qiyong Gong, Garry Gold, Vikas Gulani, Margaret Hall-Craggs, Tim Leiner, C. C.Tschoyoson Lim, James G. Pipe, Scott Reeder, Caroline Reinhold, Marion Smits, Daniel K. Sodickson, Clare Tempany, H. Alberto Vargas, Meiyun Wang

Radiology

Research output: Contribution to journal › Editorial › peer-review

27 Scopus citations

Abstract

There is increasing scrutiny from healthcare organizations towards the utility and associated costs of imaging. MRI has traditionally been used as a high-end modality, and although shown extremely important for many types of clinical scenarios, it has been suggested as too expensive by some. This editorial will try and explain how value should be addressed and gives some insights and practical examples of how value of MRI can be increased. It requires a global effort to increase accessibility, value for money, and impact on patient management. We hope this editorial sheds some light and gives some indications of where the field may wish to address some of its research to proactively demonstrate the value of MRI. Level of Evidence: 5. Technical Efficacy: Stage 5. J. Magn. Reson. Imaging 2019;49:e14–e25.

Original language	English (US)
Pages (from-to)	e14-e25
Journal	Journal of Magnetic Resonance Imaging
Volume	49
Issue number	7
DOIs	https://doi.org/10.1002/jmri.26211
State	Published - Jun 2019

Keywords

MR imaging
accessibility
costs
management
patient-centered
value

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1002/jmri.26211

Cite this

van Beek, E. J. R., Kuhl, C., Anzai, Y., Desmond, P., Ehman, R. L., Gong, Q., Gold, G., Gulani, V., Hall-Craggs, M., Leiner, T., Lim, C. C. T., Pipe, J. G., Reeder, S., Reinhold, C., Smits, M., Sodickson, D. K., Tempany, C., Vargas, H. A., & Wang, M. (2019). Value of MRI in medicine: More than just another test? Journal of Magnetic Resonance Imaging, 49(7), e14-e25. https://doi.org/10.1002/jmri.26211

van Beek, EJR, Kuhl, C, Anzai, Y, Desmond, P, Ehman, RL, Gong, Q, Gold, G, Gulani, V, Hall-Craggs, M, Leiner, T, Lim, CCT, Pipe, JG, Reeder, S, Reinhold, C, Smits, M, Sodickson, DK, Tempany, C, Vargas, HA & Wang, M 2019, 'Value of MRI in medicine: More than just another test?', Journal of Magnetic Resonance Imaging, vol. 49, no. 7, pp. e14-e25. https://doi.org/10.1002/jmri.26211

@article{ee584cffb51f4e4681ff4d2e2969fe01,

title = "Value of MRI in medicine: More than just another test?",

abstract = "There is increasing scrutiny from healthcare organizations towards the utility and associated costs of imaging. MRI has traditionally been used as a high-end modality, and although shown extremely important for many types of clinical scenarios, it has been suggested as too expensive by some. This editorial will try and explain how value should be addressed and gives some insights and practical examples of how value of MRI can be increased. It requires a global effort to increase accessibility, value for money, and impact on patient management. We hope this editorial sheds some light and gives some indications of where the field may wish to address some of its research to proactively demonstrate the value of MRI. Level of Evidence: 5. Technical Efficacy: Stage 5. J. Magn. Reson. Imaging 2019;49:e14–e25.",

keywords = "MR imaging, accessibility, costs, management, patient-centered, value",

author = "{van Beek}, {Edwin J.R.} and Christiane Kuhl and Yoshimi Anzai and Patricia Desmond and Ehman, {Richard L.} and Qiyong Gong and Garry Gold and Vikas Gulani and Margaret Hall-Craggs and Tim Leiner and Lim, {C. C.Tschoyoson} and Pipe, {James G.} and Scott Reeder and Caroline Reinhold and Marion Smits and Sodickson, {Daniel K.} and Clare Tempany and Vargas, {H. Alberto} and Meiyun Wang",

note = "Publisher Copyright: {\textcopyright} 2018 International Society for Magnetic Resonance in Medicine",

year = "2019",

month = jun,

doi = "10.1002/jmri.26211",

language = "English (US)",

volume = "49",

pages = "e14--e25",

journal = "Journal of Magnetic Resonance Imaging",

issn = "1053-1807",

publisher = "John Wiley and Sons Inc.",

number = "7",

}

TY - JOUR

T1 - Value of MRI in medicine

T2 - More than just another test?

AU - van Beek, Edwin J.R.

AU - Kuhl, Christiane

AU - Anzai, Yoshimi

AU - Desmond, Patricia

AU - Ehman, Richard L.

AU - Gong, Qiyong

AU - Gold, Garry

AU - Gulani, Vikas

AU - Hall-Craggs, Margaret

AU - Leiner, Tim

AU - Lim, C. C.Tschoyoson

AU - Pipe, James G.

AU - Reeder, Scott

AU - Reinhold, Caroline

AU - Smits, Marion

AU - Sodickson, Daniel K.

AU - Tempany, Clare

AU - Vargas, H. Alberto

AU - Wang, Meiyun

PY - 2019/6

Y1 - 2019/6

N2 - There is increasing scrutiny from healthcare organizations towards the utility and associated costs of imaging. MRI has traditionally been used as a high-end modality, and although shown extremely important for many types of clinical scenarios, it has been suggested as too expensive by some. This editorial will try and explain how value should be addressed and gives some insights and practical examples of how value of MRI can be increased. It requires a global effort to increase accessibility, value for money, and impact on patient management. We hope this editorial sheds some light and gives some indications of where the field may wish to address some of its research to proactively demonstrate the value of MRI. Level of Evidence: 5. Technical Efficacy: Stage 5. J. Magn. Reson. Imaging 2019;49:e14–e25.

AB - There is increasing scrutiny from healthcare organizations towards the utility and associated costs of imaging. MRI has traditionally been used as a high-end modality, and although shown extremely important for many types of clinical scenarios, it has been suggested as too expensive by some. This editorial will try and explain how value should be addressed and gives some insights and practical examples of how value of MRI can be increased. It requires a global effort to increase accessibility, value for money, and impact on patient management. We hope this editorial sheds some light and gives some indications of where the field may wish to address some of its research to proactively demonstrate the value of MRI. Level of Evidence: 5. Technical Efficacy: Stage 5. J. Magn. Reson. Imaging 2019;49:e14–e25.

KW - MR imaging

KW - accessibility

KW - costs

KW - management

KW - patient-centered

KW - value

UR - http://www.scopus.com/inward/record.url?scp=85052654908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052654908&partnerID=8YFLogxK

U2 - 10.1002/jmri.26211

DO - 10.1002/jmri.26211

M3 - Editorial

C2 - 30145852

AN - SCOPUS:85052654908

SN - 1053-1807

VL - 49

SP - e14-e25

JO - Journal of Magnetic Resonance Imaging

JF - Journal of Magnetic Resonance Imaging

IS - 7

ER -

Value of MRI in medicine: More than just another test?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this